Skip to main content
http://pbs.twimg.com/media/EJ5jSUbXsAEbBOC.jpg

FINCH3: FILGOTINIB studied in this cohort naive to MTX; interesting that safety data looks good! Maybe too early to tell. Abst# 927 https://t.co/AonswiGYG3 https://t.co/q3OU582WbT

Dr. John Cush
Nov-21-2019
×